カテゴリー： IMARC, 世界, 医療/バイオ

造影剤の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Contrast Media Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23AP146）◆商品コード：IMARC23AP146
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年3月2日
◆ページ数：147
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本調査資料によると、2022年に45億ドルであった世界の造影剤市場規模が、2028年までに58億ドルとなり、予測期間中にCAGR4.11%で拡大すると見込まれています。本書は、造影剤の世界市場を徹底的に分析し、市場の現状や今後の動向をまとめた資料です。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（ヨード造影剤、ガドリニウム造影剤、マイクロバブル造影剤、バリウム造影剤）分析、モダリティ別（X線/CT、磁気共鳴画像法、超音波）分析、用途別（放射線科、インターベンショナルラジオロジー、インターベンショナルカーディオロジー）分析、投与経路別（静脈内/動脈内、経口投与、直腸、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況など、以下の構成で掲載しています。また、本書内には、Bayer AG、Beijing Beilu Pharmaceuticals Company Limited、Bracco S.p.A.、General Electric Company、Guerbet、iMAX Diagnostic Imaging Limited、J.B. Chemicals & Pharmaceuticals Limited、Jodas Expoim Pvt. Ltd.、Lantheus、Nano Therapeutics Pvt Ltd、SANOCHEMIA Pharmazeutika GmbH、TAEJOON PHARM Co. Ltd. and Trivitron Healthcare.など、参入企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の造影剤市場規模：種類別
- ヨード造影剤の市場規模
- ガドリニウム造影剤の市場規模
- マイクロバブル造影剤の市場規模
- バリウム造影剤の市場規模
・世界の造影剤市場規模：モダリティ別
- X線/CTにおける市場規模
- 磁気共鳴画像法における市場規模
- 超音波における市場規模
・世界の造影剤市場規模：用途別
- 放射線科における市場規模
- インターベンショナルラジオロジーにおける市場規模
- インターベンショナルカーディオロジーにおける市場規模
・世界の造影剤市場規模：地域別
- 北米の造影剤市場規模
- アジア太平洋の造影剤市場規模
- ヨーロッパの造影剤市場規模
- 中南米の造影剤市場規模
- 中東・アフリカの造影剤市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

Market Overview:
The global contrast media market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.11% during 2023-2028.

Contrast media, also known as contrast agents, is a group of chemical agents that aid in the characterization of pathology by improving the contrast resolution of an imaging modality. It is administered through injectors via oral, intravascular, and rectal routes. It helps enhance the visibility of the targeted body organs, tissues, and blood vessels during an ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) scan. It also allows radiologists to determine the difference between aberrant and normal tissues of the body in images. As a result, contrast media finds extensive applications in the healthcare industry, especially in radiology, interventional cardiology, diagnostic imaging centers, and ambulatory surgical centers (ASCs) around the world.

Contrast Media Market Trends:
The growing global geriatric population, which is highly susceptible to various chronic medical disorders, represents one of the key factors positively influencing the market. The rising prevalence of cancer, neurological, and cardiovascular diseases are also significantly increasing the demand for diagnostic imaging procedures and contrast media. In line with this, the growing preferences for minimally invasive (MI) medical procedures and surgeries, as they require smaller incisions and cause less postoperative pain, shorter hospital stays, and faster recovery, are offering lucrative growth opportunities to manufacturers. Apart from this, due to a significant rise in medical tourism, the demand for radiopharmaceuticals is increasing across the globe. Furthermore, the advent of digital solutions for precise and effective management of contrast media is driving the demand for contrast media. This, along with the rising focus of several companies on launching innovative products to minimize waste generation during contrast media manufacturing, is strengthening the market growth. Moreover, increasing investments by several leading market players in extensive research and development (R&D) activities are anticipated to propel market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global contrast media market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, modality, application, route of administration and end user.

Breakup by Type:
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Barium-based Contrast Media

Breakup by Modality:
X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound

Breakup by Application:
Radiology
Interventional Radiology
Interventional Cardiology

Breakup by Route of Administration:
Intravenous/Intrarterial
Oral Route
Rectal Route
Others

Breakup by End User:
Hospital, Clinics and Ambulatory Surgery Centers
Diagnostic Imaging Centers

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bayer AG, Beijing Beilu Pharmaceuticals Company Limited, Bracco S.p.A., General Electric Company, Guerbet, iMAX Diagnostic Imaging Limited, J.B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus, Nano Therapeutics Pvt Ltd, SANOCHEMIA Pharmazeutika GmbH, TAEJOON PHARM Co. Ltd. and Trivitron Healthcare.

Key Questions Answered in This Report
1. What was the size of the global contrast media market in 2022?
2. What is the expected growth rate of the global contrast media market during 2023-2028?
3. What has been the impact of COVID-19 on the global contrast media market?
4. What are the key factors driving the global contrast media market?
5. What is the breakup of the global contrast media market based on the type?
6. What is the breakup of the global contrast media market based on the modality?
7. What is the breakup of the global contrast media market based on the application?
8. What is the breakup of the global contrast media market based on the route of administration?
9. What are the key regions in the global contrast media market?
10. Who are the key players/companies in the global contrast media market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Contrast Media Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Iodinated Contrast Media
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Gadolinium-based Contrast Media
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Microbubble Contrast Media
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Barium-based Contrast Media
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Modality
7.1 X-ray/Computed Tomography (CT)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Magnetic Resonance Imaging (MRI)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ultrasound
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Radiology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Interventional Radiology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Interventional Cardiology
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Intravenous/Intrarterial
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral Route
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Rectal Route
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Hospital, Clinics and Ambulatory Surgery Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Diagnostic Imaging Centers
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bayer AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Beijing Beilu Pharmaceuticals Company Limited
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Bracco S.p.A.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 SWOT Analysis
16.3.4 General Electric Company
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Guerbet
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 iMAX Diagnostic Imaging Limited
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 J.B. Chemicals & Pharmaceuticals Limited
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Jodas Expoim Pvt. Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Lantheus
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Nano Therapeutics Pvt Ltd
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 SANOCHEMIA Pharmazeutika GmbH
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 TAEJOON PHARM Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Trivitron Healthcare
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 造影剤の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Contrast Media Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 造影剤の世界市場2023-2031：産業分析、規模、シェア、成長、動向、予測
  • デジタルメディアアダプター（DMA）の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 血液培養検査の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 造影剤注入装置の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆